Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taspoglutide Gastric Emptying Study in T2DM
NCT00809705Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2008
- Primary completion
- Oct 2009
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 3 trial of taspoglutide in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Dec 2008; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00809705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809705.